Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NervGen Pharma: Proof that NVG-291 works?

It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...

Prospera Energy corporate update: 3 years of strategic restructuring, recovery and future growth

CALGARY, Alberta, Oct. 24, 2024 (GLOBE NEWSWIRE) — Prospera Energy Inc. (“PEI”) (TSX.V: PEI, OTC: GXRFF, FRA: OF6B) The 2024 Prospera corporate update outlines the company’s restructuring efforts since 2021, highlighting key m...

Buzz on the Bullboards: The top stocks in energy, mining and EVs

As investors navigate through another week of market activity, attention remains divided between Toronto and New York, with corporate earnings and a significant U.S. Federal Reserve monetary policy decision dominating discussions. In Toronto, the TSX experienc...

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Last week saw the Canadian and U.S. stock markets grappling with a host of challenges, from surging inflation data to escalating tensions in the Middle East. Adding to the mix, a historic trial commenced in New York, as former U.S. President Donald Trump faced allegations...

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...

Buzz on the Bullboards: Who’s filling the void in the tech selloff?

Last week was full of tough questions for investors navigating the waters of a sea of global economic uncertainty and confusion. Investors remain in a holding pattern as we witnessed some of the most popular companies among our communities (many in the tech sector) st...

Buzz on the Bullboards: Who’s taking off and who’s grounded

We are just around the corner from the end of the personal fiscal year, and signs of increased activity are wherever you look. Those who are looking to cash in, or brokers looking for a couple of solid deals, are making their last-minute moves while companies look to ...

Buzz on the Bullboards: New quarter, new hot stocks?

For many businesses, this time represents the beginning of the final quarter of the year. The week has ushered in a fresh yearly low for the Toronto Stock Exchange and a U.S. government narrowly avoiding a shutdown. In this week’s Buzz on the Bullboard...

Charbone Hydrogen is on a green mission

A Canadian green hydrogen group established in North America, Charbone Hydrogen, is on a mission. The Canadian hydrogen group is positioning itself as a major player in the decarbonization of our planet. The group is fully committed to the energy transition and the drive ...

Buzz on the Bullboards: Markets struggle in Q1 2023

Despite a solid start to the year, markets on Bay Street and Wall Street have struggled since fresh calendars went up. This week, Canada’s top banks have been pointing to economic pain ahead with higher loan loss provisions and a fall in quarterly prof...
1 2 3 4 5 6 7